{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:48:36Z","timestamp":1792082916876,"version":"4.4.0"},"reference-count":41,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Obesity and insulin resistance-related proteinuria is associated with oxidative stress and impaired tissue bioavailable nitric oxide. Recent data suggest that nicotinamide adenine dinucleotide phosphate oxidase-mediated oxidative injury to the proximal tubule, like that seen in the glomerulus, contributes to proteinuria in insulin-resistant states. The vasodilator \u03b2-blocker nebivolol reduces nicotinamide adenine dinucleotide phosphate oxidase activity, increases bioavailable nitric oxide, and improves insulin sensitivity. To test the hypothesis that a treatment strategy that reduces oxidative stress and attenuates obesity-associated increases in glomerular and proximal tubule derived protein, we treated young Zucker obese (ZO) and age-matched Zucker lean male rats with nebivolol (10 mg \u00b7 kg\u22121 \u00b7 d\u22121) for 21 d. Compared with Zucker lean, ZO controls exhibited increased proteinuria and \u03b3-glutamyl transpeptidase, reductions in systemic insulin sensitivity in association with increased renal renin, (pro)renin receptor, angiotensin II type 1 receptor, and mineralocorticoid receptor immunostaining, oxidative stress, and glomerular tubular structural abnormalities that were substantially improved with in vivo nebivolol treatment. Nebivolol treatment also led to improvements in glomerular podocyte foot-process effacement and improvement in podocyte-specific proteins (nephrin and synaptopodin) as well as proximal tubule-specific proteins (megalin and lysosomal-associated membrane protein-2) and proximal tubule ultrastructural remodeling in the ZO kidney. Our findings support the notion that obesity and insulin resistance lead to increased glomerulotubular oxidative stress and resultant glomerular and tubular sources of excess urine protein. Furthermore, the results of this study suggest the beneficial effect of nebivolol on proteinuria was derived from improvements in weight and insulin sensitivity and reductions in renal oxidative stress in a state of obesity and insulin resistance.<\/jats:p>","DOI":"10.1210\/en.2010-1038","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T03:19:59Z","timestamp":1293074399000},"page":"659-668","source":"Crossref","is-referenced-by-count":34,"title":["Nebivolol Attenuates Redox-Sensitive Glomerular and Tubular Mediated Proteinuria in Obese Rats"],"prefix":"10.1210","volume":"152","author":[{"given":"Javad","family":"Habibi","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin R.","family":"Hayden","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"Harry S. Truman Veterans Affairs Medical Center (J.R.S., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"Departments of Internal Medicine (J.R.S.), Columbia, Missouri 65211"},{"name":"Medical Pharmacology and Physiology (J.R.S.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Pulakat","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Tilmon","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Manrique","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Lastra","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent G.","family":"DeMarco","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"first","affiliation":[{"name":"Diabetes and Cardiovascular Center (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"},{"name":"Harry S. Truman Veterans Affairs Medical Center (J.R.S., A.W.-C.), Columbia, Missouri 65211"},{"name":"University of Missouri-Columbia School of Medicine (J.H., M.R.H., J.R.S., L.P., R.D.T., C.M., G.L., V.G.D., A.W.-C.), Columbia, Missouri 65211"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"2020071612370284000_B1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease.","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"2020071612370284000_B2","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1681\/ASN.2005060638","article-title":"Obesity and risk of chronic renal failure.","volume":"17","author":"Ejerblad","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2020071612370284000_B3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic U.S. adults.","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2020071612370284000_B4","doi-asserted-by":"crossref","first-page":"H1597","DOI":"10.1152\/ajpheart.00026.2004","article-title":"Insulin resistance and hypertension.","volume":"286","author":"Sowers","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612370284000_B5","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071612370284000_B6","doi-asserted-by":"crossref","first-page":"F125","DOI":"10.1152\/ajprenal.00248.2009","article-title":"Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.","volume":"298","author":"Jaimes","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000297290","article-title":"Oxidative and nitrosative stress and progression of diabetic nephropathy in type 2 diabetes.","volume":"31","author":"Fujii","year":"2010","journal-title":"Am J Nephrol"},{"key":"2020071612370284000_B8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1291\/hypres.23.527","article-title":"Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.","volume":"23","author":"Kakoki","year":"2000","journal-title":"Hypertens Res"},{"key":"2020071612370284000_B9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/14728214.13.3.447","article-title":"Agents in development for the treatment of diabetic nephropathy.","volume":"13","author":"Goh","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"key":"2020071612370284000_B10","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000066912.58385.DE","article-title":"Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.","volume":"107","author":"Kalinowski","year":"2003","journal-title":"Circulation"},{"key":"2020071612370284000_B11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semnephrol.2004.04.010","article-title":"L-arginine as a therapeutic tool in kidney disease.","volume":"24","author":"Klahr","year":"2004","journal-title":"Semin Nephrol"},{"key":"2020071612370284000_B12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.11.043","article-title":"The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery.","volume":"508","author":"Georgescu","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"2020071612370284000_B13","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/HJH.0b013e3282efeecb","article-title":"Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.","volume":"25","author":"Pires","year":"2007","journal-title":"J Hypertens"},{"key":"2020071612370284000_B14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/01.RES.88.1.12","article-title":"Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease.","volume":"88","author":"O'Donnell","year":"2001","journal-title":"Circ Res"},{"key":"2020071612370284000_B15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000229305","article-title":"Nebivolol reduces proteinuria and renal NADPH oxidase generated reactive oxygen species in the transgenic Ren2 rat.","volume":"30","author":"Whaley-Connell","year":"2009","journal-title":"Am J Nephrol"},{"key":"2020071612370284000_B16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000278757","article-title":"Nebivolol attenuates maladaptive proximal tubule remodeling in transgenic rats.","volume":"31","author":"Hayden","year":"2010","journal-title":"Am J Nephrol"},{"key":"2020071612370284000_B17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.hjh.0000160216.86597.ff","article-title":"Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation.","volume":"23","author":"Fratta Pasini","year":"2005","journal-title":"J Hypertens"},{"key":"2020071612370284000_B18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00005344-198805000-00007","article-title":"Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective \u03b21-adrenergic antagonist.","volume":"11","author":"Van de Water","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"2020071612370284000_B19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2125.1994.tb04342.x","article-title":"Nitric oxide mediated venodilator effects of nebivolol.","volume":"38","author":"Bowman","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"2020071612370284000_B20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/hc3001.094207","article-title":"Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.","volume":"104","author":"Tzemos","year":"2001","journal-title":"Circulation"},{"key":"2020071612370284000_B21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ndt\/14.3.620","article-title":"Urine N-acetyl-\u03b2-d-glucosaminidase\u2014a marker of tubular damage?","volume":"14","author":"Bosomworth","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"2020071612370284000_B22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1681\/ASN.2009010075","article-title":"Albuminuria, wherefore art thou?","volume":"20","author":"Jarad","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2020071612370284000_B23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2008050503","article-title":"Impaired tubular uptake explains albuminuria in early diabetic nephropathy.","volume":"20","author":"Russo","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2020071612370284000_B24","doi-asserted-by":"crossref","first-page":"F1589","DOI":"10.1152\/ajprenal.00142.2008","article-title":"Disease-dependent mechanisms of albuminuria.","volume":"295","author":"Comper","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1523-1755.2000.00836.x","article-title":"Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.","volume":"57","author":"Coimbra","year":"2000","journal-title":"Kidney Int"},{"key":"2020071612370284000_B26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000109394","article-title":"Insulin resistance, oxidative stress, and podocyte injury; role of rosuvastatin modulation of filtration barrier injury in the Zucker obese rat.","volume":"28","author":"Whaley-Connell","year":"2008","journal-title":"Am J Nephrol"},{"key":"2020071612370284000_B27","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/HYPERTENSIONAHA.109.145136","article-title":"Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat.","volume":"55","author":"Zhou","year":"2010","journal-title":"Hypertension"},{"key":"2020071612370284000_B28","doi-asserted-by":"crossref","first-page":"F1308","DOI":"10.1152\/ajprenal.00167.2006","article-title":"Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.","volume":"291","author":"Whaley-Connell","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B29","doi-asserted-by":"crossref","first-page":"F1257","DOI":"10.1152\/ajprenal.00588.2007","article-title":"Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA.","volume":"294","author":"Kobori","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-5320(66)80060-6","article-title":"Observations on the segmentation of the proximal tubule in the rat kidney.","volume":"16","author":"Maunsbach","year":"1966","journal-title":"J Ultrastruct Res"},{"key":"2020071612370284000_B31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1089\/ars.2008.2034","article-title":"Redox control of renal function and hypertension.","volume":"10","author":"Nistala","year":"2008","journal-title":"Antioxid Redox Signal"},{"key":"2020071612370284000_B32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.28.6.1047","article-title":"Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity.","volume":"28","author":"Alonso-Galicia","year":"1996","journal-title":"Hypertension"},{"key":"2020071612370284000_B33","doi-asserted-by":"crossref","first-page":"F772","DOI":"10.1152\/ajprenal.00019.2008","article-title":"Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice.","volume":"295","author":"Gonzalez-Villalobos","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ki.2009.424","article-title":"Proteinuria: an enzymatic disease of the podocyte?","volume":"77","author":"Mundel","year":"2010","journal-title":"Kidney Int"},{"key":"2020071612370284000_B35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1291\/hypres.26.413","article-title":"Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats.","volume":"26","author":"Tojo","year":"2003","journal-title":"Hypertens Res"},{"key":"2020071612370284000_B36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s004180100317","article-title":"Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats.","volume":"116","author":"Tojo","year":"2001","journal-title":"Histochem Cell Biol"},{"key":"2020071612370284000_B37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MNH.0b013e3282f4e525","article-title":"Biomarkers in acute and chronic kidney disease.","volume":"17","author":"Nickolas","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2020071612370284000_B38","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00252.2006","article-title":"Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat.","volume":"292","author":"Hayden","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071612370284000_B39","doi-asserted-by":"crossref","first-page":"13952","DOI":"10.1073\/pnas.2335190100","article-title":"Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release.","volume":"100","author":"Spahl","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071612370284000_B40","doi-asserted-by":"crossref","first-page":"L185","DOI":"10.1152\/ajplung.00267.2001","article-title":"Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein\/thionein.","volume":"282","author":"St. Croix","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2020071612370284000_B41","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/2\/659\/9015721\/endo0659.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/152\/2\/659\/9015721\/endo0659.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:55:41Z","timestamp":1594932941000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/152\/2\/659\/2457025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2010-1038","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}